Results 91 to 100 of about 14,898 (265)
American Journal of Medical Genetics Part A, Volume 197, Issue 7, July 2025.
Toru Nagata +6 more
wiley +1 more source
Response to vigabatrin in relation to seizure type. [PDF]
, 1989 Roberto Michelucci, C. A. Tassinari
openalex +1 more source
Vigabatrin Retinal Toxicity First Detected with Electroretinographic Changes: A Case Report.
Journal of Clinical & Experimental Ophthalmology, 2014 Vigabatrin is an effective antiepileptic drug (AED) typically used in the treatment of refractory partial seizures and infantile spasms. Its use, however, is limited due to the concern of retinal toxicity and subsequent visual field defects.
D. Barrett +3 more
semanticscholar +1 more source
Ketamine abuse and apoptosis in the cortex in monkeys and mice [PDF]
, 2008 International Journal of Neuropsychopharmacology, 2008, v. 11, suppl. 1, p. 236-237, abstract no.
Lam, WP +4 more
core
Chronic Toxicity Studies with Vigabatrin, A GABA-Transaminase Inhibitor [PDF]
, 1990 John P. Gibson +5 more
openalex +1 more source
PLoS ONE, 2013 Epilepsy is a common neurological disorder and cause of significant morbidity and mortality. Although antiseizure medication is the first-line treatment for epilepsy, currently available medications are ineffective in a significant percentage of patients
Bo Zhang +3 more
semanticscholar +1 more source
Evaluating Risks for Vigabatrin Treatment [PDF]
Epilepsy Currents, 2009 Approximately 30 to 40 percent of adults with epilepsy treated chronically with vigabatrin develop concentric visual field constrictions. These deficits are generally mild and asymptomatic, but are usually irreversible, so risks and benefits for vigabatrin treatment must be carefully reviewed.
openaire +2 more sources
Pharmacology Research & Perspectives, 2014 Vigabatrin is an antiepileptic drug substance mainly used in pediatric treatment of infantile spasms. The main source of nutrition for infants is breast milk and/or infant formula.
M. K. Nøhr +5 more
semanticscholar +1 more source
Study of visual field defects in patients with epilepsy receiving Vigabatrin [PDF]
, 2009 Vigabatrin, a GABA (γ-aminobutyric acid) agonist is a drug widely prescribed in Europe and Asia between 1989 and 1997 for drug resistant, partial epilepsy and has been associated with visual field defects.
Gonzalez, Pedro Antonio
core +1 more source
Treatment of Infantile Spasms: Results of a Population‐Based Study with Vigabatrin as the First Drug for Spasms [PDF]
, 1999 Marja‐Liisa Granström +2 more
openalex +1 more source